左心室辅助装置相关感染与脑血管意外风险:一项EUROMACS研究
该多中心欧洲机械循环支持患者注册研究纳入3282例耐久性左心室辅助装置患者,分析感染与脑血管意外的关联。感染作为时间依赖协变量时CVA的HR为1.90(95%CI 1.55-2.33,P<0.001),多因素分析HR为1.99(95%CI 1.62-2.45,P<0.001)。VAD特异性感染和VAD相关感染与CVA相关,非VAD相关感染无显著关联。
要点
- 感染作为时间依赖协变量时CVA的HR为1.90(95%CI 1.55-2.33,P<0.001)。
- 多因素分析确认感染与CVA关联,HR为1.99(95%CI 1.62-2.45,P<0.001)。
- VAD相关感染HR 1.99、VAD特异性感染HR 1.56与CVA相关,非VAD相关感染无显著关联。
核心结论
- LVAD支持期间感染与发生缺血性或出血性CVA风险增加相关,尤其在VAD相关或VAD特异性感染情况下。
- 作者认为这表明LVAD支持患者感染期间需要严格的抗凝管理和充分的抗生素治疗。
研究设计与样本
- 对多中心欧洲机械循环支持患者注册(EUROMACS)进行分析。
- 纳入3282例植入耐久性LVAD的患者,多数为男性(83.1%)。
- 感染分类为VAD特异性感染、VAD相关感染和非VAD相关感染。
- 采用以感染为时间依赖协变量的扩展Kaplan-Meier分析和多因素Cox比例风险模型。
主要发现
- 随访期间1262例患者发生感染,457例患者发生CVA。
- 以首次感染为时间依赖协变量的Cox回归显示CVA的HR为1.90(95%CI 1.55-2.33,P<0.001)。
- 多因素分析确认感染与CVA关联,HR为1.99(95%CI 1.62-2.45,P<0.001)。
- VAD特异性感染HR为1.56(95%CI 1.18-2.08,P 0.002),VAD相关感染HR为1.99(95%CI 1.41-2.82,P<0.001),均与CVA相关。
- 非VAD相关感染与CVA无显著关联(P=0.102)。
临床怎么用
- 作者认为LVAD支持患者感染期间需要严格的抗凝管理和充分的抗生素治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In patients supported by a durable left ventricular assist device (LVAD), infections are a frequently reported adverse event with increased morbidity and mortality. The purpose of this study was to investigate the possible association between infections and thromboembolic events, most notable cerebrovascular accidents (CVAs), in LVAD patients. METHODS: An analysis of the multicentre European Registry for Patients Assisted with Mechanical Circulatory Support was performed. Infections were categorized as VAD-specific infections, VAD-related infections and non-VAD-related infections. An extended Kaplan-Meier analysis for the risk of CVA with infection as a time-dependent covariate and a multivariable Cox proportional hazard model were performed. RESULTS: For this analysis, 3282 patients with an LVAD were included with the majority of patients being male (83.1%). During follow-up, 1262 patients suffered from infection, and 457 patients had a CVA. Cox regression analysis with first infection as time-dependent covariate revealed a hazard ratio (HR) for CVA of 1.90 [95% confidence interval (CI): 1.55-2.33; P < 0.001]. Multivariable analysis confirmed the association for infection and CVAs with an HR of 1.99 (95% CI: 1.62-2.45; P < 0.001). With infections subcategorized, VAD-specific HR was 1.56 (95% CI: 1.18-2.08; P 0.002) and VAD-related infections [HR: 1.99 (95% CI: 1.41-2.82; P < 0.001)] remained associated with CVAs, while non-VAD-related infections (P = 0.102) were not. CONCLUSIONS: Infection during LVAD support is associated with an increased risk of developing an ischaemic or haemorrhagic CVA, particularly in the setting of VAD-related or VAD-specific infections. This suggests the need of a stringent anticoagulation management and adequate antibiotic treatment during an infection in LVAD-supported patients.
引用
- Zijderhand CF, Antonides CFJ, Veen KM, et al. Left ventricular assist device-related infections and the risk of cerebrovascular accidents: a EUROMACS study. Eur J Cardiothorac Surg. 2022. PMID: 35997578. doi:10.1093/ejcts/ezac421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。